🇺🇸 FDA
Patent

US 11964003

Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

granted A61KA61K38/26A61K47/02

Quick answer

US patent 11964003 (Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same) held by XERIS PHARMACEUTICALS, INC. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K38/26, A61K47/02, A61K47/20, A61K47/34